Healthy Lungs for Life 2014 campaign VIDEO

Respiratory Decade is an active supporter of Healthy Lungs for Life 2014!! Today we are presenting Healthy Lungs for Life 2014: preview video!

Healthy Lungs for Life is one of the largest ever lung health campaigns, raising awareness of the importance of healthy lungs to healthcare professionals, scientists, primary care, patients, policy makers and the public through a full range of events, projects and promotional activities. In 2014, the theme is "Breathe clean air".

Healthy Lungs for Life 2014 campaign in the best traditions of the Year of the Lung 2010

Respiratory Decade joins Healthy Lungs for Life campaign and will support it actively via our Respiratory blog and our Respiratory facebook groups and pages! 

In 2010 was started very ambitious initiative YEAR OF THE LUNG. YEAR OF THE LUNG was the most important and the most successful Respiratory campaign which emphasized the importance of public awareness about respiratory diseases. Speaking at the European Launch, Professor Nikos Siafakas, European Respiratory Society President 2010, said that the most respiratory diseases are both preventable and treatable, treatment however is very costly, and effective prevention policies in the EU and worldwide are severely lacking”.

Healthy Lungs for Life is one of the largest ever lung health campaigns, raising awareness of the importance of healthy lungs to healthcare professionals, scientists, primary care, patients, policy makers and the public through a full range of events, projects and promotional activities. In 2014, the theme is "Breathe clean air". 

Healthy Lungs for Life seeks to reduce the number of people suffering from respiratory disease by raising awareness and knowledge of lung conditions and ways to prevent lung damage.

In 2014, Healthy Lungs for Life aims to:

• Increase knowledge of the impact of poor air quality on lung health
• Raise awareness of the actions that everyone can take to protect their own lungs from indoor and outdoor air pollution.

Organizers said: We are inviting respiratory professionals and the public from across the globe to join us in this campaign and we can help you by providing resources and materials to host your own events. We are also holding a number of events to coincide with the European Respiratory Society International Congress 2014 across Munich and at the Congress centre itself. The more people supporting and taking part in events, the more powerful the messages will be.

NEW Clinical Practice Guideline From the American College of Physicians: Diagnosis of Obstructive Sleep Apnea in Adults 2014

Dear friends today was published A Clinical Practice Guideline From the American College of Physicians: Diagnosis of Obstructive Sleep Apnea in Adults 2014!!!

 

Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the diagnosis of obstructive sleep apnea in adults.
Methods: This guideline is based on published literature on this topic that was identified by using MEDLINE (1966 through May 2013), the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included all-cause mortality, cardiovascular mortality, nonfatal cardiovascular disease, stroke, hypertension, type 2 diabetes, postsurgical outcomes, and quality of life. Sensitivities, specificities, and likelihood ratios were also assessed as outcomes of diagnostic tests. This guideline grades the evidence and recommendations by using ACP's clinical practice guidelines grading system.
Recommendation 1: ACP recommends a sleep study for patients with unexplained daytime sleepiness. (Grade: weak recommendation, low-quality evidence)
Recommendation 2: ACP recommends polysomnography for diagnostic testing in patients suspected of obstructive sleep apnea. ACP recommends portable sleep monitors in patients without serious comorbidities as an alternative to polysomnography when polysomnography is not available for diagnostic testing. (Grade: weak recommendation, moderate-quality evidence).

Qaseem A, Dallas P, Owens DK, Starkey M, Holty JC, Shekelle P, et al. Diagnosis of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2014;161:210-220. doi:10.7326/M12-3187
http://annals.org/article.aspx?articleid=1892620#.U-DiykrFNOg.hootsuite

AIRWAYS-ICPs - Integrated care pathways for airway diseases: new perspective

Dear Respiratory friends please read about new perspectives with AIRWAYS-ICPs project!

Chronic respiratory diseases are major non-communicable diseases. Asthma and allergic diseases occur throughout the life cycle and can begin during pregnancy and childhood. In Europe, they affect 30 million children and adults under 45 years of age. Chronic obstructive pulmonary disease (COPD) has an estimated annual death rate of over 4 million people globally. Among the European Union (EU) member states, asthma accounted for an average of 53 hospital admissions per 100 000 population in 2009, and the average COPD-related admission rate was 184. The annual direct and indirect costs in the 28 EU countries due to COPD or asthma are estimated at €48 billion and €34 billion, respectively. Chronic respiratory diseases affect active and healthy ageing. Asthma in children or adults is a common risk factor for COPD in adults. 

The aim of AIRWAYS-ICPs is to improve healthy life years and to reduce burden (emergency visits, avoidable hospitalisations, disability and costs) while improving quality of life worldwide, and, in the longer term, to reduce disease incidence by new and innovative prevention strategies.

AIRWAYS-ICPs has a clear strategic relevance with regard to the EU Health Strategy as it will bring added value to the existing public health knowledge:

• To propose a common framework for chronic respiratory disease (and for comorbidities) ICPs for the entire EU which can then be expanded to other regions (e.g. the Commonwealth of Independent States) and which will allow comparability and trans-national initiatives.
• To help risk stratification in chronic respiratory disease patients, using a common strategy.
• To develop cost-effective policies, in particular strengthening those on smoking and environment exposure.
• To have a significant implication on the health of citizens in the short term (reduction of morbidity, improvement of education in children and of work in adults) and in the long term (healthy ageing).
• To propose a common simulation tool for the entire EU in order to assist physicians in the segmentation of patients and in the choice of pathways. 
  
  
  
  More information was published last week in European Respiratory Journal: 
  J. Bousquet et al.
  Integrated care pathways for airway diseases (AIRWAYS-ICPs) Eur Respir J 2014 44:304-323; published ahead of print 2014, doi:10.1183/09031936.00014614
  http://erj.ersjournals.com/content/44/2/304.extract?etoc

Welcome to Annual Summit on Sleep Disorders and Medicine 2015

Dear Respiratory friends today we are happy to invite you on a Great Respiratory event 2015! It is Annual Summit on Sleep Disorders and Medicine 2015 and it is organised by OMICS Group!

OMICS Group invites you to attend the Annual Summit on Sleep Disorders and Medicine popularly known as Sleep Medicine 2015, which is going to be held during August 10^th -12^th, 2015 at San Francisco, USA.

Sleep Disorders and Sleep Therapy is a cross-disciplinary area concerned with the psycological and physical health conditions related to sleep disorders and conventional and advanced sleep therapies . The main goal of Sleep Medicine 2015 is to illuminate the gravity of the topic, how it affects our day to day lives, prevention and stairway to a healthier tomorrow.

Sleep Medicine 2015 scientific sessions focuses on understanding sleep disorders and sleeping problems, medical conditions associated with sleep disorders, effect of sleep disorders on the human body, conventional sleep medicine and sleep therapy and exciting innovations in every area of Sleep Disorders and Advanced Sleep Therapies. Sleep Medicine 2015 encompasses the popularly known causes and types of sleep disorders and also reveals the underlying psychological disorders and other unknown causes for disrupted sleep patterns. Pediatric sleep disorders throws light upon the sleep disorders that can affect children and how it effects their development. Trends in sleep medicine will focus on a variety of medical and surgical specialties including Neurology, Pulmonary Medicine, Psychiatry, Otolaryngology, Dentistry Bariatric Surgery and Nutrition.

Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorders to restless legs syndrome. They are diagnosed through comprehensive assessment, which may entail a detailed patient history, physical exam, questionnaires and sleep diaries, and clinical testing. They often are addressed in similarly comprehensive ways involving behavioral, pharmacologic and other treatments in combination with medical care. 

Annual Summit on Sleep Disorders and Medicine, will be organized around the theme "Medical conditions related to sleep disorders and advanced sleep therapy." 

Sleep Medicine 2015 is comprised of 10 tracks and 48 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutical Regulatory Affairs.

Submit your abstract to any of the following tracks:

http://sleepmedicine.conferenceseries.net/call-for-abstracts.php

All related abstracts are accepted.

The Annual Summit on Sleep Disorders and Medicine will schedule and coordinate all meetings with our Editorial Board across the World. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking information and therapeutic techniques related to Sleep Disorders.         

The main aim of Sleep Medicine 2015 is to bring awareness amongst the people about the effect of sleep disorders on health, daily routine and lives, Symptoms people normally ignore diseases that can lead to sleep disorders, prevention and therapeutic techniques.

We look forward to seeing you in San Francisco!!

World Lung Cancer Day 2014

Dear Respiratory Friends today is a World Lung Cancer Day 2014!

Please mark your calendar for August 1, 2014, the 3rd annual World Lung Cancer Day!

Join in to Celebrate, Commemorate and Support all those affected by the #1 Cancer Killer.

Lung Cancer, often referred to as the “Invisible Disease”, is generally asymptomatic and often goes undetected or misdiagnosed, while advancing to a late incurable stage. Only 15% of patients diagnosed in the late stages will survive 5 years.

Although early detection screening has been a topic of great concern and study, the guidelines established by the American Cancer Society, continue to leave a large percent of the population ineligible for screening. Anyone can get Lung cancer.

Widely portrayed and publicized as a “Smokers Disease”, over 60% of newly diagnosed patients are never smokers or quit years ago .An increasing amount of young non-smoking women are being diagnosed. Anyone with lungs can get Lung Cancer.

Lung Cancer is the #1 cancer killer in the U.S., claiming 160,000 lives annually. This is nearly 10 times the amount of lives lost to AIDS ( 18,000 annually) . Lung cancer claims more lives than breast, colon, kidney, and melanoma cancers ...combined.

This year, Lung Cancer will kill twice as many women as Breast Cancer.

Lung Cancer receives less research funding (per death) than any other type of cancer.

Radon, asbestos, diesel, poor air quality, environmental pollutants, chemical toxicity, occupational exposures, genetics, - are all known factors that contribute to causing Lung Cancer. Anyone that breathes, can get Lung Cancer.

The first question most Lung Cancer Patients are asked is “Did You Smoke?". The public perception that Lung cancer is a smoker’s disease, the “blame-the-victim” mentality and the overall stigma attached to this disease, far too often denies Lung cancer patients the support and compassion afforded other cancers and major diseases.

Lung cancer patients face the same physical, emotional and financial hardships as any other cancer. They battle the same fears, depression, losses and grueling treatments. Yet those battling receive minimal recognition and support from our society. Lung Cancer is bad-Its victims are not. Like AIDS, Alcoholism, Obesity, Drug abuse and a myriad of diseases that can be “rooted in causes” Lung cancer Patients and Caregivers deserve support, not shame and blame.

World Lung Cancer Day is a day to Celebrate, Commemorate & Support the people affected by Lung Cancer. 

Our Voice is being heard around the World, from prominent Cancer Centers to Lung Cancer Organizations & groups...But most especially, in events held to honor the people of lung cancer.
World Lung Cancer Day is recorded in Chase's Worldwide Calendar of Events (The #1 global reference source, used by News & Media for holidays & events) as an annual day of Observance for all those affected by and lost to Lung Cancer worldwide.
WLCD is an initiative driven by the People of Lung Cancer, with no Political or Organizational affiliations or global boundaries.
23+ Official Proclamations declaring August 1,WLCD have been issued in USA States & Cities. Events, vigils, Memorials, community gatherings & celebrations are being held. Social media, newspapers & magazines are promoting WLCD. Worldwide cancer centers, health groups & organizations recognize & celebrate World Lung Cancer Day-August 1.

2013 Journal Citation Reports released

2013 Journal Citation Reports released!!!

Journal Citation Reports (JCR) is a resource that allows you to evaluate and compare journals using citation data drawn from almost 11,000 scholarly and technical journals from nearly 2,500 publishers in over 80 countries. It includes virtually all areas of the sciences. Journal Citation Reports can show you the:

• Most frequently cited journals in a field
• Highest impact journals in a field
• Largest journals in a field.

Citation and article counts are indicators of how frequently current researchers are using individual journals.  The 2013 citation data is available as the 2014 Release of Journal Citation Reports on July 29, 2014.

The recognized authority for evaluating journals, JCR presents quantitative data that supports a systematic, objective review of the world’s leading journals. Using a combination of impact and influence metrics, and millions of cited and citing journal data points that comprise the complete journal citation network of Web of Science™, JCR provides the context to understand a journal’s true place in the world of scholarly literature.

Please go to below link- and then go to the section "Journal Citation Report". You can find there 2013 IFs for any Journal.

http://apps.webofknowledge.com/UA_GeneralSearch_input.do?product=UA&search_mode=GeneralSearch&SID=X2hIGpCsv5UFBZjcRUy&preferencesSaved=